VEGFA and neoplasm: These findings have pathophysiological significance as anti-angiogenic therapies based on VEGF have shown limited success in treating cancer (Lupo et al., 2016; Zarrin et al., 2017; Abdalla et al., 2018; Itatani et al., 2018) because tumor cells develop resistance over the time.